Progesterone receptor membrane component 1 modulates human cytochrome P450 activities in an isoform-dependent manner

Drug Metabolism and Disposition

Volumn 39, Issue 11, 2011, Pages 2057-2065

  Oda, Shingo ^a   Nakajima, Miki ^a   Toyoda, Yasuyuki ^a   Fukami, Tatsuki ^a   Yokoi, Tsuyoshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

7 ETHOXYCOUMARIN; CHLORZOXAZONE; CYTOCHROME B5; CYTOCHROME P450 2C9; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; DICLOFENAC; MIDAZOLAM; PROGESTERONE RECEPTOR; PROGESTERONE RECEPTOR MEMBRANE COMPONENT 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE FERRIHEMOPROTEIN REDUCTASE; TESTOSTERONE; UNCLASSIFIED DRUG; WARFARIN;

ADULT; ARTICLE; CELL STRAIN HEK293; CELL STRAIN HEPG2; DRUG METABOLISM; EMBRYO; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME SUBSTRATE; FEMALE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIVER MICROSOME; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

CYTOCHROME P-450 ENZYME SYSTEM; CYTOCHROMES B5; HEK293 CELLS; HEP G2 CELLS; HEPATOCYTES; HUMANS; MEMBRANE PROTEINS; METABOLIC DETOXICATION, DRUG; MICROSOMES, LIVER; PROTEIN BINDING; PROTEIN ISOFORMS; RECEPTORS, PROGESTERONE; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 80054739593     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.111.040907     Document Type: Article

References (30)

1. Cahill MA (2007) Progesterone receptor membrane component 1: an integrative review. J Steroid Biochem Mol Biol 105:16-36. (Pubitemid 47211947)
2. Crudden G, Loesel R, and Craven RJ (2005) Overexpression of the cytochrome p450 activator hpr6 (heme-1 domain protein/human progesterone receptor) in tumors. Tumour Biol 26:142-146. (Pubitemid 41379753)
3. Debose-Boyd RA (2007) A helping hand for cytochrome p450 enzymes. Cell Metab 5:81-83.
4. Ghosh K, Thompson AM, Goldbeck RA, Shi X, Whitman S, Oh E, Zhiwu Z, Vulpe C, and Holman TR (2005) Spectroscopic and biochemical characterization of heme binding to yeast Dap1p and mouse PGRMC1p. Biochemistry 44:16729-16736. (Pubitemid 41832053)
5. Guengerich FP (2002) Rate-limiting steps in cytochrome P450 catalysis. Biol Chem 383:1553-1564.
6. Hosomi H, Akai S, Minami K, Yoshikawa Y, Fukami T, Nakajima M, and Yokoi T (2010) An in vitro drug-induced hepatotoxicity screening system using CYP3A4-expressing and γ-glutamylcysteine synthetase knockdown cells. Toxicol In Vitro 24:1032-1038.
7. Hughes AL, Powell DW, Bard M, Eckstein J, Barbuch R, Link AJ, and Espenshade PJ (2007) Dap1/PGRMC1 binds and regulates cytochrome P450 enzymes. Cell Metab 5:143-149. (Pubitemid 46172917)
8. Iwamura A, Fukami T, Hosomi H, Nakajima M, and Yokoi T (2011) CYP2C9-mediated metabolic activation of losartan detected by a highly sensitive cell-based screening assay. Drug Metab Dispos 39:838-846.
9. Katoh M, Matsui T, Nakajima M, Tateno C, Kataoka M, Soeno Y, Horie T, Iwasaki K, Yoshizato K, and Yokoi T (2004) Expression of human cytochromes P450 in chimeric mice with humanized liver. Drug Metab Dispos 32:1402-1410. (Pubitemid 39564560)
10. Kronbach T, Mathys D, Umeno M, Gonzalez FJ, and Meyer UA (1989) Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4. Mol Pharmacol 36:89-96. (Pubitemid 19191264)
11. Laird SM, Vinson GP, and Whitehouse BJ (1988) Monoclonal antibodies against rat adrenocortical cell antigens. Acta Endocrinol (Copenh) 119:420-426.
12. Locuson CW, Gannett PM, and Tracy TS (2006) Heteroactivator effects on the coupling and spin state equilibrium of CYP2C9. Arch Biochem Biophys 449:115-129.
13. Lösel RM, Besong D, Peluso JJ, and Wehling M (2008) Progesterone receptor membrane component 1 - many tasks for a versatile protein. Steroids 73:929-934.
14. Mansouri MR, Schuster J, Badhai J, Stattin EL, Lösel R, Wehling M, Carlsson B, Hovatta O, Karlström PO, Golovleva I, et al. (2008) Alterations in the expression, structure and function of progesterone receptor membrane component-1 (PGRMC1) in premature ovarian failure. Hum Mol Genet 17:3776-3783.
15. 5-like ligand-binding domain. Genome Biol 3:RESEARCH0068.
16. Min L, Takemori H, Nonaka Y, Katoh Y, Doi J, Horike N, Osamu H, Raza FS, Vinson GP, and Okamoto M (2004) Characterization of the adrenal-specific antigen IZA (inner zone antigen) and its role in the steroidogenesis. Mol Cell Endocrinol 215:143-148. (Pubitemid 38333253)
17. Min L, Strushkevich NV, Harnastai IN, Iwamoto H, Gilep AA, Takemori H, Usanov SA, Nonaka Y, Hori H, Vinson GP, et al. (2005) Molecular identification of adrenal inner zone antigen as a heme-binding protein. FEBS J 272:5832-5843. (Pubitemid 41689355)
18. Mohri T, Nakajima M, Fukami T, Takamiya M, Aoki Y, and Yokoi T (2010) Human CYP2E1 is regulated by miR-378. Biochem Pharmacol 79:1045-1052.
19. Nakajima M, Nakamura S, Tokudome S, Shimada N, Yamazaki H, and Yokoi T (1999) Azelastine N-demethylation by cytochrome P-450 (CYP)3A4, CYP2D6, and CYP1A2 in human liver microsomes: evaluation of approach to predict the contribution of multiple CYPs. Drug Metab Dispos 27:1381-1391.
20. Nebert DW and Russell DW (2002) Clinical importance of the cytochromes P450. Lancet 360:1155-1162. (Pubitemid 35246494)
21. Nelson DR, Zeldin DC, Hoffman SM, Maltais LJ, Wain HM, and Nebert DW (2004) Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics 14:1-18. (Pubitemid 38183957)
22. Peluso JJ, Liu X, Saunders MM, Claffey KP, and Phoenix K (2008a) Regulation of ovarian cancer cell viability and sensitivity to cisplatin by progesterone receptor membrane component-1. J Clin Endocrinol Metab 93:1592-1599. (Pubitemid 351656493)
23. Peluso JJ, Romak J, and Liu X (2008b) Progesterone receptor membrane component-1 (PGRMC1) is the mediator of progesterone's antiapoptotic action in spontaneously immortalized granulosa cells as revealed by PGRMC1 small interfering ribonucleic acid treatment and functional analysis of PGRMC1 mutations. Endocrinology 149:534-543. (Pubitemid 351159360)
24. Rohe HJ, Ahmed IS, Twist KE, and Craven RJ (2009) PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding. Pharmacol Ther 121:14-19.
25. Shimada T, Yamazaki H, Mimura M, Inui Y, and Guengerich FP (1994) Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414-423. (Pubitemid 24229655)
26. Szczesna-Skorupa E and Kemper B (2011) Progesterone receptor membrane component 1 inhibits the activity of drug-metabolizing cytochromes P450 and binds to cytochrome P450 reductase. Mol Pharmacol 79:340-350.
27. Tabata T, Katoh M, Tokudome S, Hosakawa M, Chiba K, Nakajima M, and Yokoi T (2004) Bioactivation of capecitabine in human liver: involvement of the cytosolic enzyme on 5′-deoxy-5-fluorocytidine formation. Drug Metab Dispos 32:762-767. (Pubitemid 38821879)
28. Wu W, Shi SQ, Huang HJ, Balducci J, and Garfield RE (2011) Changes in PGRMC1, a potential progesterone receptor, in human myometrium during pregnancy and labour at term and preterm. Mol Hum Reprod 17:233-242.
29. Yamazaki H, Gillam EM, Dong MS, Johnson WW, Guengerich FP, and Shimada T (1997) Reconstitution of recombinant cytochrome P450 2C10(2C9) and comparison with cytochrome P450 3A4 and other forms: effects of cytochrome P450-P450 and cytochrome P450-b5 interactions. Arch Biochem Biophys 342:329-337. (Pubitemid 27251255)
30. Yamazaki H, Tanaka M, and Shimada T (1999) Highly sensitive high-performance liquid chromatographic assay for coumarin 7-hydroxylation and 7-ethoxycoumarin O-deethylation by human liver cytochrome P450 enzymes. J Chromatogr B Biomed Sci Appl 721:13-19. (Pubitemid 29017686)